Skip to main content
Caplight Logo









EyeControl

EyeControl

Private
Tel AvivHealthcare & Life Scienceshttps://www.eyecontrol.co.il/

Last Round

Grant

May 1, 2024

Total Funding Raised

$13.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EyeControl is a health tech company that develops an AI-powered, wearable eye-tracking platform designed to enable communication for mechanically ventilated patients and individuals with locked-in syndrome.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, NLP & Conversational AI, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Application

Keywords

eye-tracking technologyassistive communicationAACaugmentative and alternative communicationmedical deviceALS communicationlocked-in syndromegaze trackingassistive techspeech generation devicescreenless technologyeye-controlled speechwearable medical devicedigital healthhealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EyeControl Comparables

Compare EyeControl with similar companies based on industry and business-model similarity.

EyeControl comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Irisbond
81%
Eyegaze Inc.
80%
Control Bionics Ltd
78%

EyeControl Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2024
GrantJan 1, 2024
Series AAug 12, 2020
GrantAug 12, 2020
GrantFeb 29, 2020
VC Round
Oct 21, 2019

Key People

Founding team and executive leadership

Itai Kornberg

Co-Founder, CTO - EyeControl

Founding Team

Or Retzkin

Co Founder & CEO

Founding Team

EyeControl Investors

Notable investors and investment history

EyeControl investors
InvestorRounds
European Innovation Council FundGrant
Connecticut InnovationsVC Round, Series A
a2 CollectiveGrant
Menomadin FoundationSeries A
RimonciSeries A
Zora VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 4013% MoM, from 15 to 617.

  • May 1, 2024

    $200K grant round from Grow with Google.

EyeControl Filings

Explore SEC and related filing metadata, where available.

EyeControl filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EyeControl's valuation, stock price, and market status.

Is EyeControl a public or private company?

EyeControl is a private company.

What is the current stock price of EyeControl?

EyeControl is a private company with no public stock price. No recent secondary market data is available.

How much is EyeControl worth (valuation)?

Valuation information for EyeControl is not publicly available.

Can I buy EyeControl stock?

EyeControl shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EyeControl's last funding round?

EyeControl's most recent funding round was Grant on May 1, 2024.

Who are the main investors in EyeControl?

Key investors in EyeControl include Connecticut Innovations, Menomadin Foundation.

Will EyeControl IPO soon?

No public IPO plans have been announced for EyeControl.

How can I track EyeControl secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EyeControl's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range18
Year Founded2016
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?